OctPGMSGp pathway control state: Difference between revisions

From Bioblast
No edit summary
No edit summary
ย 
Line 8: Line 8:


This substrate combination supports convergent electron flow to the [[Q-junction]].
This substrate combination supports convergent electron flow to the [[Q-junction]].
|info=[[MiPNet21.06 SUIT reference protocol]]
|info=[[MiPNet21.06 SUIT RP]]
}}
{{MitoPedia concepts
|mitopedia concept=SUIT state
}}
}}
::: ''More details'' ย 
::: ''More details'' ย 
Line 39: Line 36:
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]
----
----
{{MitoPedia concepts
|mitopedia concept=SUIT state
}}

Latest revision as of 05:02, 19 July 2022


high-resolution terminology - matching measurements at high-resolution


OctPGMSGp pathway control state

Description

OctPGMSGp: Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate & Glycerophosphate.

MitoPathway control state: FNSGp

SUIT protocol: SUIT-002

This substrate combination supports convergent electron flow to the Q-junction.

Abbreviation: OctPGMSGp

Reference: MiPNet21.06 SUIT RP

More details
ยป Additive effect of convergent electron flow
ยป Respiratory complexes - more than five
ยป FNSGp
ยป Convergent electron flow

OctPGMSGpL

OctPGMSGpP

OctPGMSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:

OctPGMSGpE

OctPGMSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:



SUIT RP2



MitoPedia concepts: SUIT state 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.